对于神经系统疾病的纳米疗法的最新进展
Arti Vashist1,2, Pandiaraj Manickam3,4, Andrea D Raymond1,2
1Department of Immunology and Nanomedicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida 33199, United States.
ACS applied bio materials
|June 27, 2023
概括
开发先进的纳米疗法为神经系统疾病提供了新的希望. 这些基于纳米技术的治疗方法旨在克服药物限制和免疫挑战,以获得更好的神经退行性疾病治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 神经系统疾病对全球健康和经济构成重大负担.
- 现有的神经退行性疾病治疗方法面临诸多挑战,包括副作用和免疫反应,阻碍了临床转化.
- 迫切需要创新的治疗策略来解决这些局限性.
研究的目的:
- 审查用于治疗神经退行性疾病的纳米治疗的最新进展.
- 探索基于纳米技术的载体在克服当前治疗挑战和神经免疫相互作用方面的潜力.
- 为神经疾病治疗纳米技术的未来发展提供见解.
主要方法:
- 对神经退行性疾病纳米治疗药物当前文献的综述.
- 纳米技术应用的分析,包括CRISPR/Cas9和siRNA传递系统.
- 从介质干细胞,树突细胞和巨细胞对工程外体进行检查,用于治疗和免疫调节.
主要成果:
- 纳米技术在提高神经系统疾病的治疗效果和疗效方面具有显著的潜力.
- 在神经退行性疾病中,工程外体显示出有希望的针对性传递和免疫反应的调节.
- 涉及纳米载体与基因编辑工具或RNA干扰的组合疗法正在推进向治疗方法.
结论:
- 纳米疗法,特别是工程外体和组合疗法,为克服目前神经退行性疾病治疗的局限性提供了有希望的途径.
- 基于纳米技术的纳米载体的进步对于开发针对神经系统疾病的个性化和有效疗法至关重要.
- 对纳米载体的进一步研究具有解决复杂的神经免疫相互作用和改善临床翻译的巨大潜力.
更多相关视频
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.6K
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
10.9K
相关概念视频
Microorganisms in Medicine and Therapeutics
68
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
68
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607
